FCGR3A and posterior cortical atrophy: To further assess the clinical importance of FcγRIIIa mRNA expression in PCa progression, we examined FcγRIIIa mRNA expression in primary tumors from the TCGA PCa cohort, which were divided into four subgroups based on the Gleason grade scores (n = 333 cases) [34].